News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why The Ionis Pharma (IONS) Spinoff Will Be A Win For Long-Term Investors



4/19/2017 6:00:23 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Last month's announcement by Ionis Pharmaceuticals (NASDAQ:IONS) that the company was spinning off its Akcea subsidiary had some investors scratching their heads. Why was the company seemingly giving up so much for so little gain? It turns out that management has its focus squarely on the future, and long-term investors should be happy about the move.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES